MarketCap
Facebook
X
Telegram
Land |
 Vereinigte Staaten |
IPO-Jahr |
2021 |
Branche |
Pharmaeinzelhändler |
Börse |
NASDAQ GLOBAL |
Anteile |
1.05 M |
Marktkapitalisierung |
$ 4.12 M |
EBITDA (LTM) |
- |
P/E (LTM) |
- |
P/S (LTM) |
- |
EPS (LTM) |
- |
Andere Aktien der Branche "Pharmaeinzelhändler"
| Name | Preis | % 24h | Marktkapitalisierung | Börse | Land | |
|---|---|---|---|---|---|---|
 |
Genmab A/S
GMAB
|
$ 55.1 | -0.77 % | $ 3.57 B | Nasdaq Global Select Market |  Danmark |
 |
GeoVax Labs
GOVX
|
$ 0.17 | 0.55 % | $ 163 K | Nasdaq Global Select Market | USA |
 |
Grifols, S.A.
GRFS
|
$ 8.58 | 0.23 % | $ 5.83 B | Nasdaq Global Select Market |  Spain |
 |
Theravance Biopharma
TBPH
|
$ 17.03 | 0.03 % | $ 857 M | Nasdaq Global Select Market |  Cayman-islands |
 |
Immuron Limited
IMRN
|
$ 0.85 | -1.17 % | $ 196 M | Nasdaq Global Select Market |  Australia |
 |
Immunic
IMUX
|
$ 7.92 | 4.23 % | $ 1.23 B | Nasdaq Global Select Market | USA |
 |
INmune Bio
INMB
|
$ 1.33 | 0.76 % | $ 32.9 M | Nasdaq Capital Market | USA |
 |
IMV
IMV
|
- | - | $ 13.1 M | Nasdaq Global Select Market |  Canada |
 |
Karuna Therapeutics
KRTX
|
- | - | $ 12.2 B | Nasdaq Global Market,SPB | USA |
 |
Chimerix
CMRX
|
- | - | $ 756 M | Nasdaq Global Select Market | USA |
 |
Atreca
BCEL
|
- | -11.76 % | $ 5.79 M | Nasdaq Global Select Market | USA |
 |
LogicBio Therapeutics
LOGC
|
- | - | $ 229 M | Nasdaq Global Market | USA |
 |
89bio
ETNB
|
- | - | $ 1.55 B | Nasdaq Global Market | USA |
 |
Fusion Pharmaceuticals
FUSN
|
- | - | $ 1.41 B | Nasdaq Global Select Market | Canada |
 |
Gritstone Oncology
GRTS
|
- | 0.42 % | $ 213 M | Nasdaq Global Select Market | USA |
 |
Harpoon Therapeutics
HARP
|
- | - | $ 763 M | Nasdaq Global Select Market | USA |
 |
HOOKIPA Pharma
HOOK
|
- | -6.92 % | $ 79.4 M | Nasdaq Global Select Market | USA |
 |
Guardion Health Sciences
GHSI
|
- | -0.31 % | $ 3.64 M | Nasdaq Capital Market | USA |
 |
Opiant Pharmaceuticals
OPNT
|
- | - | $ 109 M | Nasdaq Global Select Market | USA |
 |
Akouos
AKUS
|
- | 0.23 % | $ 488 M | Nasdaq Global Select Market | USA |
 |
Otonomy
OTIC
|
- | -1.96 % | $ 4.68 M | Nasdaq Global Select Market | USA |
 |
Aridis Pharmaceuticals
ARDS
|
- | 17.91 % | $ 11.1 M | Nasdaq Capital Market | USA |
 |
Seagen
SGEN
|
- | - | $ 42.2 B | Nasdaq Global Select Market,SPB | USA |
 |
Baudax Bio
BXRX
|
- | 0.59 % | $ 63 K | Nasdaq Capital Market | USA |
 |
ChemoCentryx
CCXI
|
- | - | $ 3.74 B | Nasdaq Global Select Market,SPB | USA |
 |
Avid Bioservices
CDMO
|
- | - | $ 789 M | Nasdaq Capital Market | USA |
 |
Zosano Pharma Corporation
ZSAN
|
- | 7.23 % | $ 2.72 M | Nasdaq Global Select Market | USA |
 |
Oncternal Therapeutics
ONCT
|
- | -24.12 % | $ 1.56 M | Nasdaq Capital Market | USA |
 |
Iterum Therapeutics
ITRM
|
- | - | $ 591 K | Nasdaq Global Select Market |  Irlanda |
 |
Spectrum Pharmaceuticals
SPPI
|
- | - | $ 189 M | Nasdaq Global Select Market | USA |
 |
Applied Genetic Technologies Corporation
AGTC
|
- | - | $ 26.5 M | Nasdaq Global Select Market | USA |
 |
Alpine Immune Sciences
ALPN
|
- | - | $ 2.17 B | Nasdaq Global Market | USA |
 |
Concert Pharmaceuticals
CNCE
|
- | - | $ 401 M | Nasdaq Global Market | USA |
 |
ImmunoGen
IMGN
|
- | - | $ 7.92 B | Nasdaq Global Select Market | USA |
 |
Vascular Biogenics Ltd.
VBLT
|
- | -8.77 % | $ 12.4 M | Nasdaq Global Select Market |  Israel |
 |
Histogen
HSTO
|
- | 31.6 % | $ 2.12 M | Nasdaq Global Select Market | USA |
 |
Berkeley Lights
BLI
|
- | -7.31 % | $ 87 M | Nasdaq Global Select Market | USA |
 |
Cidara Therapeutics
CDTX
|
- | - | $ 1.41 B | Nasdaq Global Market | USA |
 |
Clovis Oncology
CLVS
|
- | -7.23 % | $ 13 M | Nasdaq Global Select Market | USA |
 |
Kaleido Biosciences
KLDO
|
- | -3.69 % | $ 12.4 M | Nasdaq Global Select Market | USA |
 |
VBI Vaccines
VBIV
|
- | -50.87 % | $ 1.09 M | Nasdaq Capital Market | USA |
 |
CTI BioPharma Corp.
CTIC
|
- | - | $ 1.2 B | Nasdaq Capital Market | USA |
 |
Decibel Therapeutics
DBTX
|
- | - | $ 123 M | Nasdaq Global Select Market | USA |
 |
NuCana plc
NCNA
|
$ 1.02 | 0.99 % | $ 11.5 B | Nasdaq Global Select Market |  Britain |
 |
PhaseBio Pharmaceuticals
PHAS
|
- | 7.4 % | $ 6.29 M | Nasdaq Global Market | USA |
 |
Provention Bio
PRVB
|
- | - | $ 2.37 B | Nasdaq Global Select Market | USA |
 |
IVERIC bio
ISEE
|
- | - | $ 5.51 B | Nasdaq Global Select Market | USA |
 |
Reata Pharmaceuticals
RETA
|
- | - | $ 6.29 B | Nasdaq Global Market,SPB | USA |
 |
ObsEva SA
OBSV
|
- | -15.52 % | $ 10.5 M | Nasdaq Global Select Market |  Schweiz |